H. Albrecht et al., TREATMENT OF ATYPICAL LEISHMANIASIS WITH INTERFERON-GAMMA RESULTING IN PROGRESSION OF KAPOSIS-SARCOMA IN AN AIDS PATIENT, The Clinical investigator, 72(12), 1994, pp. 1041-1047
Visceral leishmaniasis (kala-azar) affecting HIV-infected patient is b
eing reported in increasing frequency. A 40-year-old German bisexual p
atient with full-blown AIDS is described who presented with Kaposi's s
arcoma, epigastric pain, diarrhea, and weight loss but without fever.
Leishmania amastigotes were initially found in biopsies from stomach,
duodenum, and a cutaneous Kaposi's sarcoma lesion but were later also
recovered from bone marrow and lymph node. The patient received three
courses of a combination of pentavalent antimony and interferon-gamma.
In addition to the common side effects such as fever, thrombocytopeni
a, and elevated amylase and lipase, a vivid progression of the Kaposi'
s sarcoma was noted. Tumor progression was temporally closely associat
ed with treatment with interferon-gamma. Because this phenomemon has a
lso been observed in other patients, we advise caution when using inte
rferon-gamma in patients with Kaposi's sarcoma.